Drug-free Alzheimer’s treatment to seek FDA approval
Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
Israel’s researchers are making inroads against the devastating and fatal condition through brain science, drugs and memory enhancement.
In an impressive year for Israeli science, ISRAEL21c reviews some of its most popular stories of the year, from breakthroughs in cancer, to mind-controlled computing and solar windows.